Literature DB >> 1675639

Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.

T Baba1, K L Black, K Ikezaki, K N Chen, D P Becker.   

Abstract

Intracarotid infusions of leukotriene C4 (LTC4) were used to open selectively the blood-brain barrier (BBB) in ischemic tissue after middle cerebral artery (MCA) occlusion in rats. BBB permeability was determined by quantitative autoradiography using [14C]aminoisobutyric acid. Seventy-two hours after MCA occlusion, LTC4 (4 micrograms total dose) infused into the carotid artery ipsilateral to the MCA occlusion selectively increased the unidirectional transfer constant for permeability Ki approximately threefold within core ischemic tissue and tissue adjacent ot the ischemic core. No effect on BBB permeability was seen within nonischemic brain tissue or in ischemic tissue after only 24 h after MCA occlusion. gamma-Glutamyl transpeptidase (gamma-GTP) activity was decreased in capillaries in ischemic tissue at 48 and 72 h after infarction, compared to high gamma-GTP in normal brain capillaries and moderate gamma-GTP in capillaries in the ischemic tissue at 24 h after infarction. These findings suggest that normal brain capillaries resist the vasogenic effects of LTC4. In contrast, LTC4 increases permeability in capillaries of ischemic tissue, where gamma-GTP is decreased. gamma-Glutamyl transpeptidase, an enzyme that inactivates LTC4 to LTD4 and LTE4 to LTF4, may act as an "enzymatic barrier" in normal brain capillaries to leukotrienes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675639     DOI: 10.1038/jcbfm.1991.115

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  12 in total

Review 1.  Blood-brain barrier and new approaches to brain drug delivery.

Authors:  W M Pardridge; R J Boado; K L Black; P A Cancilla
Journal:  West J Med       Date:  1992-03

Review 2.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

3.  Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury.

Authors:  Santiago Farias; Lauren C Frey; Robert C Murphy; Kim A Heidenreich
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

4.  Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils.

Authors:  A M Rao; J F Hatcher; M S Kindy; R J Dempsey
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

5.  Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier.

Authors:  Longkun Zhu; Ravi Maruvada; Adam Sapirstein; Kafait U Malik; Marc Peters-Golden; Kwang Sik Kim
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

6.  Delayed bilateral craniectomy for treatment of traumatic brain swelling in children: case report and review of the literature.

Authors:  Thomas Reithmeier; Bernhard Speder; Paul Pakos; Gerret Brinker; Mario Löhr; Norfrid Klug; Ralf-Ingo Ernestus
Journal:  Childs Nerv Syst       Date:  2005-01-08       Impact factor: 1.475

7.  Transferrin-antibody fusion proteins are effective in brain targeting.

Authors:  S U Shin; P Friden; M Moran; T Olson; Y S Kang; W M Pardridge; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Multiple mechanisms underlying neuroprotection by secretory phospholipase A2 preconditioning in a surgically induced brain injury rat model.

Authors:  Yuechun Wang; Prativa Sherchan; Lei Huang; Onat Akyol; Devin W McBride; John H Zhang
Journal:  Exp Neurol       Date:  2017-10-24       Impact factor: 5.330

9.  The effects of montelukast on random pattern skin flap survival: An experimental study in rats.

Authors:  Kaan Gideroglu; Fahrettin Yilmaz; Fadullah Aksoy; Guler Bugdayci; Husamettin Cakici; Onur Hapa
Journal:  Curr Ther Res Clin Exp       Date:  2008-10

Review 10.  Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.

Authors:  Paolo Gelosa; Francesca Colazzo; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.